Millennium Management
CNTB

Millennium Management’s Connect Biopharma Holdings CNTB Stock Holding History

Millennium Management’s Portfolio CNTB Stock Details CNTB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.24M Buy
474,601
+427,551
+909% +$1.11M ﹤0.01% 4225
2025
Q4 		$133K Buy
+47,050
New +$100K ﹤0.01% 5579
2021
Q3 		– Sell
-42,856
Closed -$837K – 6833
2021
Q2 		$837K Buy
42,856
+31,757
+286% +$530K ﹤0.01% 4833
2021
Q1 		$205K Buy
+11,099
New +$189K ﹤0.01% 5482

Other funds holding CNTB

IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
RB
Richmond Brothers Jackson, Michigan $150M AUM 14.02% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return
DMKJ
David M. Knott Jr $168M AUM 60.36% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Millennium Management's CNTB Position: Q1 2026 in Review

Millennium Management increased its Connect Biopharma Holdings (CNTB) stake by 909% in Q1 2026, buying an estimated $1.11M and bringing the position to 474,601 shares worth $1.24M. The position accounts for ﹤0.01% of the portfolio, ranked #4225.

Millennium Management first reported a position in CNTB in Q1 2021 and has held it in 4 quarters since. 41 funds tracked by Wall St. Rank hold CNTB as of Q1 2026.

  • Millennium Management held 474,601 shares of Connect Biopharma Holdings worth $1.24M as of Q1 2026.
  • Millennium Management bought 427,551 Connect Biopharma Holdings shares in Q1 2026, an estimated $1.11M.
  • Connect Biopharma Holdings made up ﹤0.01% of Millennium Management's portfolio in Q1 2026, its #4225 holding.
  • Millennium Management first reported a position in Connect Biopharma Holdings in Q1 2021 and has held it in 4 quarters since.
  • 41 funds tracked by Wall St. Rank held Connect Biopharma Holdings as of Q1 2026.

Based on Millennium Management's 13F filing for Q1 2026, filed 15 May 2026.